R. Goode

发表

Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.

L. Black, R. Goode, Larry John Black, 1980, Life sciences.

LY207320 (6‐methylene‐4‐pregnene‐3,20‐dione) inhibits testosterone biosynthesis, androgen uptake, 5α‐reductase, and produces prostatic regression in male rats

N. Stamm, B. Neubauer, R. E. Toomey, 1993 .

Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase

K. Bemis, B. Neubauer, J. Audia, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells

N. Bruchovsky, Chung Lee, J. Krushinski, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α‐reductase inhibitor

B. Neubauer, J. Audia, D. Sutkowski, 1996, The Prostate. Supplement.

Antagonism of androgen and estrogen effects in guinea pig seminal vesicle epithelium and fibromuscular stroma by keoxifene (LY156758)

David C. Jones, B. Neubauer, A. Mariotti, 1989, The Prostate.

Differential interaction of antiestrogens with cytosol estrogen receptors

L. Black, Larry J. Black, C. David Jones, 1981, Molecular and Cellular Endocrinology.

Metabolism and Biological Activity of Benzo[a]pyrene and Its Metabolic Products

D. Jerina, A. Conney, G. Holder, 1977 .

Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat

K. Bemis, B. Neubauer, R. Merriman, 1986, The Prostate.

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

Tao Wang, Hong Zhang, N. Dean, 2007, The Journal of clinical investigation.

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

R. Campbell, P. Iversen, J. Graff, 2005 .

In vivo assay for conversion of testosterone to dihydrotestosterone by rat prostatic steroid 5α‐reductase and comparison of two inhibitors

B. Neubauer, R. E. Toomey, V. Petrow, 1991, The Prostate.

The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.

David C. Jones, J. Graff, B. Neubauer, 2003, Cancer research.

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat.

J. D. Frank, B. Neubauer, R. Merriman, 1988, Thrombosis research.

Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.

L. Black, R. Goode, Larry John Black, 1981, Endocrinology.

Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.

M. Heiman, D. Robertson, B. Neubauer, 1992, Cancer research.

Mesenchymal-epithelial interactions as factors influencing male accessory sex organ growth in the rat.

B. Neubauer, D. Hoover, K. Best, 1986, Federation proceedings.

Growth regulation of prostatic stromal cells by prostate-specific antigen.

G W Becker, H. Hsiung, P. Cohen, 1999, Journal of the National Cancer Institute.

Mutagenic and cytotoxic activity of benzol[a]pyrene 4,5-, 7,8-, and 9,10-oxides and the six corresponding phenols.

D. Jerina, A. Conney, W. Levin, 1975, Proceedings of the National Academy of Sciences of the United States of America.

Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.

F. Tinsley, B. Neubauer, K. S. Hirsch, 1990, Toxicology and applied pharmacology.

Raloxifene (LY156758) produces antimetastatic responses and extends survival in the paiii rat prostatic adenocarcinoma model

B. Neubauer, R. Merriman, M. Sarosdy, 1995, The Prostate.

Androgens lower prostaglandin E2 levels in neonatal mouse bulbourethral gland in in vitro cultures.

B. Neubauer, R. E. Toomey, J. S. Little, 1992, Endocrinology.

Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[ƒ]quinolinones derived from palladium mediated coupling reactions

B. Neubauer, J. Audia, V. P. Rocco, 1998 .

Synthesis and 5α‐Reductase Inhibitory Activity of 8‐Substituted Benzo[f]quinolinones Derived from Palladium Mediated Coupling Reactions.

B. Neubauer, J. Audia, E. C. Smith, 2010 .

A small molecule inhibitor of TGFβ RI kinase potentiates VEGF dependent angiogenesis in vitro

J. Yingling, R. Foreman, M. Uhlik, 2006 .

Metabolism and Biological Activity

D. Jerina, A. Conney, G. Holder, 1977 .

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.

K. Bemis, B. Neubauer, R. Merriman, 1986, The Journal of urology.

Responses of LNCaP prostatic adenocarcinoma cell cultures to LY300502, a benzoquinolinone human type I 5α‐reductase inhibitor

B. Neubauer, J. Audia, K. Hsiao, 1996 .

Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.

J. Howbert, B. Neubauer, R. Merriman, 1992, The Journal of urology.

Endocrine and antiprostatic effects of raloxifene (LY156758) in the male rat

J. Clemens, B. Neubauer, R. E. Toomey, 1993, The Prostate.